Shenzhen Lifotronic Technology Co (688389) — Strategic Asset Allocation Index
Shenzhen Lifotronic Technology Co (688389) has a Strategic Asset Allocation Index of 28.5% as of June 2023. Strategic assets (PP&E of CN¥441.62 Million plus long-term investments of CN¥-) total CN¥441.62 Million, measured against net assets of CN¥1.55 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Shenzhen Lifotronic Technology Co to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Shenzhen Lifotronic Technology Co Strategic Asset Allocation Index (2019–2021)
This chart shows how Shenzhen Lifotronic Technology Co's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2021. As of June 2023, the index stands at 28.5%, representing strategic assets of CN¥441.62 Million against net assets of CN¥1.55 Billion CNY. For live market cap and overall valuation, see market cap of Shenzhen Lifotronic Technology Co.
Annual Strategic Asset Allocation Index for Shenzhen Lifotronic Technology Co (2019–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Lifotronic Technology Co from 2019 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 688389 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 23.7% | CN¥298.15 Million | CN¥298.15 Million | CN¥- | CN¥1.26 Billion | ▲ +5.4 pp |
| 2020 | 18.3% | CN¥209.29 Million | CN¥209.29 Million | CN¥- | CN¥1.14 Billion | ▲ +1.0 pp |
| 2019 | 17.3% | CN¥181.66 Million | CN¥181.66 Million | CN¥- | CN¥1.05 Billion | — |